Last update 21 Nov 2024

BBM-D101

Overview

Basic Info

Drug Type
AAV based gene therapy
Synonyms
Target
UTRN x dystrophin
Mechanism
UTRN modulators(Utrophin modulators), dystrophin modulators(Dystrophin modulators)
Therapeutic Areas
Nervous System DiseasesCongenital DisordersSkin and Musculoskeletal Diseases+ [1]
Active Indication
Muscular Dystrophy, Duchenne
Inactive Indication-
Originator Organization
Belief BioMed, Inc.Startup
Active Organization
Shanghai Mianyi Biopharmaceutical Co., Ltd.Shanghai Jiao Tong University School of MedicineBelief BioMed, Inc.Startup
Inactive Organization-
Drug Highest PhaseEarly Phase 1
First Approval Date-
RegulationRare Pediatric Disease (US), Orphan Drug (US)
Login to view timeline

Related

1
Clinical Trials associated with BBM-D101
NCT06641895 / RecruitingEarly Phase 1IIT
A Single-Arm, Open-Label, Single-Dose Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of BBM-D101 Injection in Patients With Duchenne Muscular Dystrophy
100 Clinical Results associated with BBM-D101
Login to view more data
100 Translational Medicine associated with BBM-D101
Login to view more data
100 Patents (Medical) associated with BBM-D101
Login to view more data
100 Deals associated with BBM-D101
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Muscular Dystrophy, DuchennePhase 1
CN
Shanghai Mianyi Biopharmaceutical Co., Ltd.
25 Jul 2024
Muscular Dystrophy, DuchennePhase 1
CN
Shanghai Jiao Tong University School of Medicine
25 Jul 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free